Repurposing Grants for the Rest of the World (ReGRoW)

Repurposing Grants for the Rest of the World (ReGRoW) is sponsored by ReGRoW. This opportunity supports mission-aligned projects and measurable outcomes.

ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries - REMEDi4ALL Hit enter to search or ESC to close Funding Calls Database « All Calls ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries This Request for Proposals (RFP) provides grants for clinical repurposing trials led by researchers and clinicians based in low and lower-middle income countries (LMICs), as defined by the World Bank (https://data.

worldbank. org/products/wdi-maps). This RFP is seeking clinical repurposing trials to address any unsolved disease facing patients in LMICs.

However, CWR has a preference for trials that address high disease burden (https://ourworldindata. org/burden-of-disease) whether non-communicable diseases; communicable diseases; maternal, neonatal and nutritional diseases; or injuries.

Repurposed therapies must be approved and/or generally recognized as safe for human use by some regulatory agency, such as the US Food and Drug Administration, European Medicines Agency, Health Canada or Japan’s Pharmaceuticals and Medical Devices Agency, and can include generic drugs, nutraceuticals or indigenous therapies.

These repurposed therapies must be tested in a new indication for which they are not already approved or used widely in clinical practice as standard of care. Repurposed therapies also may be added to current standard of care to improve patient outcomes and/or quality of life. CWR is accepting budgets of up to US$70,000 for this funding opportunity.

All submissions must include ideas and/or plans to engage the community of interest before, during and after the proposed clinical trial. CWR will provide up to US$8,500 in additional financial support for community engagement, with at least US$4,000 required for community engagement. CWR has a 2-stage submission process, starting with the brief Letter of Intent (LOI).

The top-rated LOI submissions will be invited to submit a full scientific proposal. All submissions are ProposalCentral (https://proposalcentral. com).

Search for “Cures Within Reach” and submit your proposal using the “Repurposing Research in LMICs” program. The LOI submission deadline is 11:59pm U.S. Eastern Time on April 10, 2026. Deadline First stage (LOI / pre-proposal) Deadline Full Application Grant Decision – Final Decision – Awarding Interested in joining this call?

Non-dilutive (grant, donation etc) Philanthropic organisation – national The REMEDi4ALL project has received funding from the European Union’s Horizon Europe Research & Innovation programme under grant agreement No 101057442.

About Us REMEDi4ALL is an EU-funded research initiative transforming drug repurposing by building a state-of-the-art platform, uniting global expertise, and accelerating access to cost-effective treatments for patients in need. DEMO PROJECTS To test the platform’s viability and robustness we support real-world projects on infectious diseases, rare cancers, and rare/ultra rare diseases.

i DR The International Drug Repurposing (iDR) Conference Series is an annual global conference series where key opinion leaders from research and patient communities, funders, regulators and representatives from the private sector participate to collectively advance innovative drug repurposing in Europe and beyond.

Explore the iDR conference series 2026 International Drug Repurposing Conference Medicines Reimagined Newsletter DRUG REPURPOSING CONCIERGE Get expert guidance for your drug repurposing project. Through a 30-minute consultation, our experts help you explore scientific support, regulatory pathways, advocacy opportunities and funding options.

With 250+ inquiries answered and a 100% response rate, the Concierge is your first stop within REMEDi4ALL for navigating the path from discovery to market. PROJECT PARTNERING PORTAL Advance your repurposing project with REMEDi4ALL through a formalised partnership.

Following a thorough evaluation process, selected projects are onboarded to work hand-in-hand with multidisciplinary teams, providing support from early discovery to regulatory approval to patient access. All potential applicants are strongly advised to engage with the Drug Repurposing Concierge before submitting partnering proposals.

REMED i 4ALL Repurposing Academy A range of training resources designed to provide a comprehensive understanding of the drug repurposing landscape. REMEDi4ALL Digital Academy The Digital Academy is our online home for on demand training on repurposing. REMEDi4ALL Bootcamps Our Bootcamps are short, in person training events that provide the chance to meet others in the drug repurposing field.

REMEDi4ALL Webinars Our webinars provide accessible, live training on specific stages of the repurposing journey. REMEDi4ALL Hackathon Join a small team of international trainees to learn on a week-long residential course where you aim to plan the development of a repurposing candidate. Resources We’re a dynamic community dedicated to drug repurposing, we produce a wide range of valuable resources.

Explore our collection here. In-silico Drug Repurposing Catalogue Practical Guide to Creating Joint Funding Calls for Drug Repurposing Research Framework for Judging the Project Value of Repurposed Medicines MEDICINES REIMAGINED Join a vibrant community to connect and collaborate to advance drug repurposing. FUNDERS NETWORK Public and private funders worldwide driving innovation in drug repurposing.